Literature DB >> 15811172

Differences in the single-oral-dose pharmacokinetics and urinary excretion of paracetamol and its conjugates between Hong Kong Chinese and Caucasian subjects.

J A J H Critchley1, L A H Critchley, P J Anderson, B Tomlinson.   

Abstract

BACKGROUND AND OBJECTIVES: The present study was conducted to determine if ethnic differences exist for single oral dose pharmacokinetics of paracetamol and its conjugates between Hong Kong Chinese and Caucasian subjects.
METHODS: Twenty healthy Chinese (n = 11) and Caucasian (n = 9) subjects, aged 21-44 years, 11 male and nine female, were given oral paracetamol syrup 20 mg/kg, following an overnight fast. Paracetamol and its metabolites (glucuronide, sulphate, cysteine and mercapturic acid conjugates) were measured in serial plasma samples (0.25, 0.5, 0.75, 1.0, 1.5, 2, 3,...,12, 24 h) and urine collections (0-24 h) by high-performance liquid chromatography.
RESULTS: In Chinese subjects, the (mean range) peak plasma concentration of paracetamol was 23.8 mug/mL (17.9-32.3) and time to attain this peak 0.66 h (0.5-0.75). This was lower (P < 0.015) at 18.7 microg/mL (14.4-22.9) and achieved later (P < 0.033) at 1.06 h (0.5-2.0) in Caucasians. In Chinese subjects, plasma levels of glucuronide were lower, sulphate higher and cysteine conjugates significantly lower than in Caucasians (P < 0.05). Chinese subjects excreted 6% more sulphate and 5% less glucuronide. They also excreted significantly less mercapturic acid conjugates (P < 0.001). DISCUSSION AND
CONCLUSION: Chinese subjects show more rapid absorption of paracetamol, a tendency to produce less glucuronide but more sulphate conjugates and reduced production of cysteine and mercapturic acid conjugates. The latter may help to protect against hepatotoxicity following paracetamol overdose.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15811172     DOI: 10.1111/j.1365-2710.2004.00626.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  22 in total

1.  Effect of a cyclooxygenase-2 inhibitor on postexercise muscle protein synthesis in humans.

Authors:  Nicholas A Burd; Jared M Dickinson; Jennifer K Lemoine; Chad C Carroll; Bridget E Sullivan; Jacob M Haus; Bozena Jemiolo; Scott W Trappe; Gordon M Hughes; Charles E Sanders; Todd A Trappe
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

2.  Safety and pharmacokinetics of the CIME combination of drugs and their metabolites after a single oral dosing in healthy volunteers.

Authors:  Natacha Lenuzza; Xavier Duval; Grégory Nicolas; Etienne Thévenot; Sylvie Job; Orianne Videau; Céline Narjoz; Marie-Anne Loriot; Philippe Beaune; Laurent Becquemont; France Mentré; Christian Funck-Brentano; Loubna Alavoine; Philippe Arnaud; Marcel Delaforge; Henri Bénech
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-12-03       Impact factor: 2.441

3.  PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses.

Authors:  Liudmila L Mazaleuskaya; Katrin Sangkuhl; Caroline F Thorn; Garret A FitzGerald; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2015-08       Impact factor: 2.089

4.  Physiologically based modeling of the pharmacokinetics of acetaminophen and its major metabolites in humans using a Bayesian population approach.

Authors:  Todd J Zurlinden; Brad Reisfeld
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-01-31       Impact factor: 2.441

5.  Race, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American Volunteers.

Authors:  Michael H Court; Zhaohui Zhu; Gina Masse; Su X Duan; Laura P James; Jerold S Harmatz; David J Greenblatt
Journal:  J Pharmacol Exp Ther       Date:  2017-06-29       Impact factor: 4.030

6.  Characterizing the Effects of Race/Ethnicity on Acetaminophen Pharmacokinetics Using Physiologically Based Pharmacokinetic Modeling.

Authors:  Todd J Zurlinden; Brad Reisfeld
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

7.  Using Physiologically Based Pharmacokinetic (PBPK) Modelling to Gain Insights into the Effect of Physiological Factors on Oral Absorption in Paediatric Populations.

Authors:  Angela Villiger; Cordula Stillhart; Neil Parrott; Martin Kuentz
Journal:  AAPS J       Date:  2016-04-08       Impact factor: 4.009

8.  The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure.

Authors:  Michael H Court; Marina Freytsis; Xueding Wang; Inga Peter; Chantal Guillemette; Suwagmani Hazarika; Su X Duan; David J Greenblatt; William M Lee
Journal:  J Pharmacol Exp Ther       Date:  2013-02-13       Impact factor: 4.030

9.  A novel approach for estimating ingested dose associated with paracetamol overdose.

Authors:  Todd J Zurlinden; Kennon Heard; Brad Reisfeld
Journal:  Br J Clin Pharmacol       Date:  2015-12-09       Impact factor: 4.335

10.  Ontogeny of Hepatic Sulfotransferases and Prediction of Age-Dependent Fractional Contribution of Sulfation in Acetaminophen Metabolism.

Authors:  Mayur K Ladumor; Deepak Kumar Bhatt; Andrea Gaedigk; Sheena Sharma; Aarzoo Thakur; Robin E Pearce; J Steven Leeder; Michael B Bolger; Saranjit Singh; Bhagwat Prasad
Journal:  Drug Metab Dispos       Date:  2019-05-17       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.